Manufacturer of Controlled Substances Registration: S & B Pharma, Inc., 3988 [2015-01287]

Download as PDF 3988 Federal Register / Vol. 80, No. 16 / Monday, January 26, 2015 / Notices DEPARTMENT OF JUSTICE ingredients (APIs) for sale to its customers. Drug Enforcement Administration Dated: January 9, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator. [Docket No. DEA–392] Manufacturer of Controlled Substances Registration: Boehringer Ingelheim Chemical, Inc. ACTION: Controlled Substance [FR Doc. 2015–01289 Filed 1–23–15; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Notice of registration. Boehringer Ingelheim Chemical, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Boehringer Ingelheim Chemical, Inc. registration as a manufacturer of the controlled substances. Drug Enforcement Administration By notice dated May 28, 2014, and published in the Federal Register on June 4, 2014, 79 FR 32321, Boehringer Ingelheim Chemical, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805–9372, applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice. The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Boehringer Ingelheim Chemical, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances: SUMMARY: SUMMARY: SUPPLEMENTARY INFORMATION: emcdonald on DSK67QTVN1PROD with NOTICES Controlled substance Schedule Amphetamine (1100) .................... Methylphenidate (1724) ................ Methadone (9250) ........................ Methadone Intermediate (9254) ... II II II II The company plans to manufacture the listed controlled substances in bulk for sale to its customers for formulation into finished pharmaceuticals. In reference to methadone intermediate (9254) the company plans to produce methadone HCL active pharmaceutical VerDate Sep<11>2014 18:48 Jan 23, 2015 Jkt 235001 [Docket No. DEA–392] Manufacturer of Controlled Substances Registration: S & B Pharma, Inc. ACTION: S & B Pharma, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants S & B Pharma, Inc. registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated July 1, 2014, and published in the Federal Register on July 8, 2014, 79 FR 38564, S & B Pharma, Inc., DBA Norac Pharma, 405 South Motor Avenue, Azusa, California 91702–3232 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice. The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of S & B Pharma, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed: Schedule Gamma Hydroxybutyric Acid (2010). Tetrahydrocannabinols (7370) ..... Methamphetamine (1105) ............ PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 II II II II II The company plans to manufacture the listed controlled substances in bulk for use in product development and for commercial sales to its customers. Dated: January 9, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2015–01287 Filed 1–23–15; 8:45 am] BILLING CODE P Notice of registration. Controlled Substance Pentobarbital (2270) ..................... Nabilone (7379) ............................ 4-Anilino-N-phenethyl-4-piperidine (ANPP) (8333). Tapentadol (9780) ........................ Fentanyl (9801) ............................ Schedule I I II DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Manufacturer of Controlled Substances Registration: Research Triangle Institute ACTION: Notice of registration. Research Triangle Institute applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Research Triangle Institute registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated July 2, 2014, and published in the Federal Register on July 14, 2014, 79 FR 40781, Research Triangle Institute, Kenneth S. Rehder, Ph.D., Hermann Building East Institute Drive, P.O. Box 12194, Research Triangle Park, North Carolina 27709, applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice. The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Research Triangle Institute to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. SUMMARY: E:\FR\FM\26JAN1.SGM 26JAN1

Agencies

[Federal Register Volume 80, Number 16 (Monday, January 26, 2015)]
[Notices]
[Page 3988]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01287]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: S & B Pharma, 
Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: S & B Pharma, Inc. applied to be registered as a manufacturer 
of certain basic classes of controlled substances. The DEA grants S & B 
Pharma, Inc. registration as a manufacturer of those controlled 
substances.

SUPPLEMENTARY INFORMATION: By notice dated July 1, 2014, and published 
in the Federal Register on July 8, 2014, 79 FR 38564, S & B Pharma, 
Inc., DBA Norac Pharma, 405 South Motor Avenue, Azusa, California 
91702-3232 applied to be registered as a manufacturer of certain basic 
classes of controlled substances. No comments or objections were 
submitted to this notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823(a) and determined that the registration of S & 
B Pharma, Inc. to manufacture the basic classes of controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed:

------------------------------------------------------------------------
            Controlled Substance                       Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)...........  I
Tetrahydrocannabinols (7370)...............  I
Methamphetamine (1105).....................  II
Pentobarbital (2270).......................  II
Nabilone (7379)............................  II
4-Anilino-N-phenethyl-4-piperidine (ANPP)    II
 (8333).
Tapentadol (9780)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for use in product development and for commercial sales to its 
customers.

    Dated: January 9, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01287 Filed 1-23-15; 8:45 am]
BILLING CODE P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.